A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma
Clinical trial NCT00930514 · COMPLETED
Trial details
- NCT number
- NCT00930514
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-07-01
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.